Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Dual-species biofilms of <i>S</i>. <i>mutans</i> and <i>C</i>. <i>albicans</i> on the dentin surface after pH cycling study showing sparse biofilm development on SDF exposed dentin... by Suphanida Kaewkamchai (19762172)

Subjects:

Mean lesion depth of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Subjects:

Mean mineral density of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Subjects:

Representative SEM images of the dentin surface topography of the three SDF test groups and the SDF-free group. by Suphanida Kaewkamchai (19762172)

Subjects:

Typical X-ray diffraction patterns of the dentin of the three SDF treated groups and the control group. by Suphanida Kaewkamchai (19762172)

Subjects:

The schematic illustration of the experimental process. by Suphanida Kaewkamchai (19762172)

Subjects:

The viability of <i>S</i>. <i>mutans</i> and <i>C</i>. <i>albicans</i> (log CFU/ml) and the wet weight of dual-species biofilms (mg) of the experimental and the control groups afte... by Suphanida Kaewkamchai (19762172)

Subjects:

Supplementary data: Flowchart of the study. by Suphanida Kaewkamchai (19762172)

Subjects:

Restricted cubic spline plots showing the association between changes in PAL and risk of CVD. by Haiwei Li (282229)

Ingenuity pathway analysis. by Wendy J. Bailey (14926392)

“…Serum thyroid hormone measurements revealed a decrease in triiodothyronine (T3) levels in homozygotes at 12 months of age, as well as a decrease in tetraiodothyronine (T4) levels at 6–9 months and at 12 months of age in both heterozygotes and homozygotes. …”

NS delays the formation of atherosclerotic plaques in ApoE^-/- mouse models. by Yihua Wang (491766)

Subjects:

NS attenuates ox-LDL-induced foam cell formation. by Yihua Wang (491766)

Subjects:

NS affects the PI3K/AKT/mTOR pathway in RAW264.7 cells. by Yihua Wang (491766)

Subjects:

Primers used for RT-qPCR. by Yihua Wang (491766)

Subjects:

NS effectively modulates the PI3K/Akt/mTOR signaling pathway and inhibits lipid transport, inflammation, and apoptosis in macrophages by enhancing autophagy. by Yihua Wang (491766)

Subjects:

NS co-suppresses Ox-LDL-induced apoptosis in RAW264.7 cells. by Yihua Wang (491766)

Subjects:

NS enhances autophagy inhibits atherosclerosis in RAW264.7 cells. by Yihua Wang (491766)

Subjects:

NS affects lipid transport in ApoE^-/-mouse models. by Yihua Wang (491766)

Subjects: